Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Upexi, Inc.

GRVINASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$4.95
$0.35(7.61%)
U.S. Market opens in 12h 1m

Upexi, Inc. (GRVI) Stock Overview

Explore Upexi, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap88.9M
P/E Ratio-2.42
EPS (TTM)$0.19
ROE-1.20%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$1.45

GRVI Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Upexi, Inc. (GRVI) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $1.45.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -2.42 and a market capitalization of 88.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
-5.53%
Year-to-Date (YTD) Change
N/A
1-Year Change
4.65%
3-Year Change
-11.61%
5-Year Change
-11.61%
All-Time (Max) Change
-11.61%

Contact Information

701-353-5425
1710 Whitney Mesa Drive, Henderson, NV, 89014

Company Facts

1,220 Employees
IPO DateJun 24, 2021
CountryUS

Frequently Asked Questions